Larimar Therapeutics (LRMR) Gains from Sales and Divestitures (2019)
Historic Gains from Sales and Divestitures for Larimar Therapeutics (LRMR) over the last 1 years, with Q4 2019 value amounting to $15267.0.
- Larimar Therapeutics' Gains from Sales and Divestitures changed N/A to $15267.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $15267.0, marking a year-over-year change of. This contributed to the annual value of $15267.0 for FY2019, which is N/A changed from last year.
- Latest data reveals that Larimar Therapeutics reported Gains from Sales and Divestitures of $15267.0 as of Q4 2019.
- In the past 5 years, Larimar Therapeutics' Gains from Sales and Divestitures registered a high of $15267.0 during Q4 2019, and its lowest value of $15267.0 during Q4 2019.